Physician profile
Daniel Mackey
NPI 1013996362
$1,088.63
in general payments reported to CMS, 2019-2025
18 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.71 · 2020: $147 · 2021: $335 · 2022: $76.88 · 2023: $174 · 2024: $212 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $338.11 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.92 | 2020-2022 | |
| Novo Nordisk INC | $73.72 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $67.50 | 2021-2025 | Airsupra |
| Pfizer INC. | $63.13 | 2020-2024 | |
| Janssen Pharmaceuticals, INC | $61.66 | 2020-2021 | |
| Amgen INC. | $49.81 | 2021-2024 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $45.66 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Abbott Laboratories | $45.16 | 2021-2025 | Freestyle Libre 3 |
| Abbvie INC. | $43.65 | 2021-2024 | |
| Eisai INC. | $29.78 | 2021 | |
| Inspire Medical Systems, INC. | $26.34 | 2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $20.54 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.38 | 2021 | |
| Corcept Therapeutics | $18.49 | 2024 | Korlym |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $18.25 | 2021 | |
| Phathom Pharmaceuticals, INC. | $17.93 | 2025 | Voquezna |
| Biohaven Pharmaceuticals, INC. | $15.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.